文献速递心境障碍

重复经颅磁刺激治疗重性抑郁发作急性期的系统综述与网络Meta分析

Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2017-01-01

结果显示,优于假刺激的模式包括启动低频、双侧、高频、θ爆发和低频rTMS;新型rTMS(加速、同步、深部)未优于假刺激。各模式可接受性至少与假刺激相当,但部分比较证据不精确。

要点

  • 优于假刺激的rTMS模式:启动低频、双侧、高频、θ爆发和低频rTMS。
  • 新型rTMS(加速、同步、深部)未显示优于假刺激,证据不支持其用于MDD。
  • 所有rTMS模式可接受性至少与假刺激相当,但部分比较证据不精确。

核心结论

  • 不同rTMS模式间临床疗效与可接受性差异较少,一定程度上支持双侧rTMS和启动低频rTMS。
  • 现有证据不能支持新型rTMS干预作为MDD的治疗。

研究设计与样本

  • 系统综述与网络Meta分析,检索PubMed/MEDLINE、EMBASE、PsycInfo和Web of Science至2016年10月1日。
  • 纳入比较任何rTMS干预与假刺激或另一种rTMS干预的随机临床试验,排除少于10次治疗的试验。

主要发现

  • 优于假刺激的干预:启动低频(OR 4.66;95% CI 1.70-12.77)、双侧(OR 3.96;95% CI 2.37-6.60)、高频(OR 3.07;95% CI 2.24-4.21)、θ爆发刺激(OR 2.54;95% CI 1.07-6.05)、低频(OR 2.37;95% CI 1.52-3.68)rTMS。
  • 新型rTMS干预(加速、同步和深部rTMS)未比假刺激更有效。
  • 除θ爆发刺激与假刺激比较外,缓解率结果相似。
  • 所有干预的可接受性至少与假刺激相当。

关键数值与推荐

  • 主要结局为应答率和可接受性(脱落率),次要结局为缓解。
  • 效应量以比值比(OR)及95% CI报告。
  • 治疗排名提示启动低频和双侧rTMS可能为最有效且可接受性最好的rTMS策略,但结果不精确且除低频、高频和双侧rTMS外可用试验相对较少。

临床怎么用

  • 临床可优先考虑双侧rTMS或启动低频rTMS作为MDD急性期治疗选择。
  • 不推荐将加速、同步或深部rTMS等新型模式用于MDD常规治疗。
  • 选择rTMS模式时需结合疗效与可接受性,并注意部分比较证据不精确。

局限性

  • 除低频、高频和双侧rTMS外,其他干预的试验数量相对较少。
  • 部分比较结果不精确。
  • 需要更大规模的随机对照试验验证这些方法在MDD短期治疗中的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although several strategies of repetitive transcranial magnetic stimulation (rTMS) have been investigated as treatment of major depressive disorder (MDD), their comparative efficacy and acceptability is unknown. OBJECTIVE: To establish the relative efficacy and acceptability of the different modalities of rTMS used for MDD by performing a network meta-analysis, obtaining a clinically meaningful treatment hierarchy. DATA SOURCES: PubMed/MEDLINE, EMBASE, PsycInfo, and Web of Science were searched up until October 1, 2016. STUDY SELECTION: Randomized clinical trials that compared any rTMS intervention with sham or another rTMS intervention. Trials performing less than 10 sessions were excluded. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers used standard forms for data extraction and quality assessment. Random-effects, standard pairwise, and network meta-analyses were performed to synthesize data. MAIN OUTCOMES AND MEASURES: Response rates and acceptability (dropout rate). Remission was the secondary outcome. Effect sizes were reported as odds ratios (ORs) with 95% CIs. RESULTS: Eighty-one studies (4233 patients, 59.1% women, mean age of 46 years) were included. The interventions more effective than sham were priming low-frequency (OR, 4.66; 95% CI, 1.70-12.77), bilateral (OR, 3.96; 95% CI, 2.37-6.60), high-frequency (OR, 3.07; 95% CI, 2.24-4.21), θ-burst stimulation (OR, 2.54; 95% CI, 1.07-6.05), and low-frequency (OR, 2.37; 95% CI, 1.52-3.68) rTMS. Novel rTMS interventions (accelerated, synchronized, and deep rTMS) were not more effective than sham. Except for θ-burst stimulation vs sham, similar results were obtained for remission. All interventions were at least as acceptable as sham. The estimated relative ranking of treatments suggested that priming low-frequency and bilateral rTMS might be the most efficacious and acceptable interventions among all rTMS strategies. However, results were imprecise and relatively few trials were available for interventions other than low-frequency, high-frequency, and bilateral rTMS. CONCLUSIONS AND RELEVANCE: Few differences were found in clinical efficacy and acceptability between the different rTMS modalities, favoring to some extent bilateral rTMS and priming low-frequency rTMS. These findings warrant the design of larger RCTs investigating the potential of these approaches in the short-term treatment of MDD. Current evidence cannot support novel rTMS interventions as a treatment for MDD. TRIAL REGISTRATION: clinicaltrials.gov Identifier: PROSPERO CRD42015019855.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry. 2017. PMID: 28030740. doi:10.1001/jamapsychiatry.2016.3644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。